Emergence of ancient convalescent plasma (CP) therapy: To manage COVID-19 pandemic - 31/01/21
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Since December 2019, the human populations of the 195 global countries continue experiencing grave health and life threats due to the current COVID-19 pandemic. As a result of the novelty of the pathogen, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), at present there is lack of preventive as well as therapeutic options for treating and managing the infection. The use of ancient immunotherapeutic technique – the convalescent plasma (CP) therapy, may act as an immediate and available option to control the COVID-19 pandemic. This review provides a concept and understanding on the CP therapy, its potential to control SARS-CoV-2 pandemic. The CP therapy might act as an immediate saviour for society from the virus. Although the CP therapy has exert affirmative result against COVID-19 it has not been recommended for long time use in COVID-19 and this review gives support for its possible application.
Le texte complet de cet article est disponible en PDF.Keywords : Convalescent plasma (CP) therapy, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Coronavirus disease 2019 (COVID-19), Passive immune therapy, Antibody-dependent enhancement (ADE)
Plan
Vol 28 - N° 1
P. 123-127 - février 2021 Retour au numéro
Article précédent
- Review of indications for immunoglobulin (IG) use: Narrowing the gap between supply and demand
- A. Brand, V. De Angelis, T. Vuk, O. Garraud, M. Lozano, D. Politis, on behalf of European Mediterranean Initiative for Transfusion Medicine
Bienvenue sur EM-consulte, la référence des professionnels de santé.